Creo Medical UK Ltd - Modern Slavery Transparency Statement - January 2023

Introduction to Creo Medical UK Ltd

Creo Medical UK Ltd is both a manufacturer and supplier of Medical devices and consumables to a global customer base. This statement is made pursuant to section 54 of the Modern Slavery Act 2015. It constitutes Creo Medical UK Ltd slavery and human trafficking statement for the financial year ended 30th September 2022. It covers the activities of Creo Medical UK Ltd and its wholly-owned subsidiaries.

Our Supply Chain

The Company uses a wide range of suppliers who supply goods for sale, provide services and support the operations of the Company. These include a small number of suppliers, direct or indirect, in countries deemed to be higher risk, based on the Global Slavery Index. Policies and procedures are in place that aim to minimise the risk of modern slavery in our supply chain. Specifically: Our Suppliers and Partners Policy sets out requirements for the buying of goods and services; a Responsible Procurement Policy covering issues of human rights, child and forced labour and modern slavery, these form part of our contractual relationship with suppliers; and a Whistleblowing Policy that encourages staff to report any concerns including specific reference to modern slavery, child and forced labour. Detailed due diligence is carried out on those suppliers where there may be a modern slavery risk. This includes a requirement for new suppliers to complete a modern slavery questionnaire and to provide a satisfactory audit report carried out by an independent, accredited auditor. An annual audit report, as part of ongoing supplier monitoring procedures, is also required. Training is provided to those employees responsible for managing contractual relationships and in purchasing goods from countries where there may be a greater risk.

Approval

This statement has been approved by the Management of Creo Medical UK Ltd and the Board of Directors of Creo Medical and signed on their behalf.
Signed:

Luis Collantes MBA
CEO
Creo Medical UK Ltd